American Healthtech Company Signs MOU to Work on Strategic Initiatives in Thailand

Nov 2019

The Thailand Centre of Excellence for Life Sciences (TCELS), a public organization under the Ministry of Higher Education, Science, Research and Innovation and an American healthtech company, PhenoMx have signed a memorandum of understanding (MOU) to develop strategic initiatives for Thailand in the areas of biomedical, life sciences and Medical device industries.

PhenoMx uses non-invasive MRI Scanning to asses the major vital organs and tissues of the whole body, including tissue types, bone, muscle, water weight, and fat percentages for precision medicine, personalized wellness, & increasing longevity. The company has developed proprietary imaging biomarkers based on years of research and data analytics.

The MOU includes matchmaking between companies and research institutes in Thailand and the US to encourage more collaboration between different stakeholders across targeted industries, as well as fostering innovation and commercialization. Specific areas of focus include artificial intelligence, big data, Medical imaging with potential projects for aging-cohort studies, biobanking, and national dementia screening.

(Sources: The New Economy; Thailand Medical News)

About Us

Orissa International helps companies that want to develop a market entry strategy for Southeast Asia or implement their business expansion into the region. We have very strong domain knowledge of markets and industry sectors, and a business network of over 16,000 companies that includes distributors, resellers, system integrators and local manufacturers, that we have built through advising and guiding more than 5,000 companies with their market expansion into the ASEAN region over the last 25 years.

Orissa International is headquartered in Singapore, with additional offices in Malaysia, Indonesia, Thailand, Vietnam, and the Philippines.

Our Services